Menu Search
Equities

Dr Reddy's Laboratories Ltd

DRREDDY:NSI

Dr Reddy's Laboratories Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)5,811.60
  • Today's Change12.05 / 0.21%
  • Shares traded22.65k
  • 1 Year change+31.08%
  • Beta0.2440
Data delayed at least 15 minutes, as of May 18 2024 08:16 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 18-May-23
  • 15-Feb-24
  • 14-Mar-24
  • 18-Apr-24
  • 16-May-24
Select bar for recommendation details.
Recommendations16-May-24
Buy5
Outperform7
Hold9
Underperform8
Sell4

Share price forecast in INR

The 35 analysts offering 12 month price targets for Dr Reddy's Laboratories Ltd have a median target of 6,050.00, with a high estimate of 7,500.00 and a low estimate of 4,245.00. The median estimate represents a 4.13% increase from the last price of 5,810.00.
High29.1%7,500.00
Med4.1%6,050.00
Low-26.9%4,245.00

Dividends in INR

In 2024, Dr Reddy's Laboratories Ltd reported a dividend of 40.00 INR, equaling last years dividend. The 26 analysts covering the company expect dividends of 41.79 INR for the upcoming fiscal year, an increase of 4.46%.
Div growth (TTM)0.00%
More ▼

Earnings history & estimates in INR

On May 07, 2024, Dr Reddy's Laboratories Ltd reported 4th quarter 2024 earnings of 78.35 per share. This result exceeded the 73.29 consensus of the 5 analysts covering the companyand exceeded last year's 4th quarter results by 35.84%.
The next earnings announcement is expected on Jul 24, 2024.
Average growth rate+9.85%
Dr Reddy's Laboratories Ltd reported annual 2024 earnings of 334.59 per share on May 07, 2024.
Average growth rate+24.16%
More ▼

Revenue history & estimates in INR

Dr. Reddy's Laboratories Limited had 4th quarter 2024 revenues of 71.14bn. This missed the 71.16bn consensus estimate of the 16 analysts following the company. This was 35.94% above the prior year's 4th quarter results.
Average growth rate+3.07%
Dr. Reddy's Laboratories Limited had revenues for the full year 2024 of 280.11bn. This was 13.54% above the prior year's results.
Average growth rate+12.57%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.